Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10945992 Dosage forms of rofecoxib and related methods

Patent 10945992 was granted and assigned to Tremeau Pharmaceuticals, Inc. on March, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
‌
Tremeau Pharmaceuticals, Inc.
0
Date Filed
May 5, 2020
0
Date of Patent
March 16, 2021
0
Patent Applicant
‌
Tremeau Pharmaceuticals, Inc.
0
Patent Application Number
16867514
0
Patent Citations Received
‌
US Patent 11872206 Purified forms of rofecoxib, methods of manufacture and use
0
‌
US Patent 11576890 Purified forms of rofecoxib, methods of manufacture and use
0
‌
US Patent 11617735 Purified forms of rofecoxib, methods of manufacture and use
0
‌
US Patent 11858909 Deuterated etoricoxib, methods of manufacture, and use thereof
0
‌
US Patent 11559509 Purified forms of rofecoxib, methods of manufacture and use
Patent Inventor Names
Travis E. Helm
0
Bradford C. Sippy
0
Raymond D. Skwierczynski
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10945992
0
Patent Primary Examiner
‌
Svetlana M Ivanova
0

Find more entities like US Patent 10945992 Dosage forms of rofecoxib and related methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo